Canada: Intellectual Property Weekly Abstracts Alert - Week Of December 19, 2011

Last Updated: January 2 2012
Most Read Contributor in Canada, September 2016

Edited by Chantal Saunders and Beverley Moore

Action Dismissed and Trial Date Released Notwithstanding Pending Appeal
Teva Canada Limited v. Wyeth LLC and Pfizer Canada Inc.

In a previous decision, the Court granted the motion for a summary trial and held that Teva could not continue ratiopharm's claim for damages under section 8 of the NOC Regulations.

This is a motion by Wyeth and Pfizer to have the action dismissed and for directions as to costs. Teva argued that the action should not be dismissed yet and the trial date, currently set for the beginning of 2013, should be preserved as Teva has appealed the decision of the Court regarding the continuation of the action. The Court found that it may not be possible to complete the appeal process prior to the date scheduled for trial, and that other litigants are seeking trial dates. The Court therefore dismissed the action and released the trial date, but stated that the Order will include the right of the parties to apply for an expedited trial date if necessary. The Court awarded costs to Wyeth and Pfizer arising after the date of the merger between Teva and ratiopharm because ratiopharm had a valid cause of action prior to that date.

Enantiomer Not Considered Innovative Drug Despite Extensive Clinical Data
Takeda Canada Inc. v. Minister of Health
Drug: DEXILANT dexlansoprazole

This is a judicial review of the decision of the Minister of Health (Minister), refusing to list DEXILANT on the Register of Innovative Drugs (Register). The medicinal ingredient in DEXILANT is an enantiomer of lansoprazole, which is contained in a marketed drug.

The Court noted that Takeda filed a New Drug Submission for the approval of its drug, containing extensive clinical trial data to establish the safety and efficacy of the product. The Minister refused to list the product on the Register on the basis that it did not meet the definition of "innovative drug".

The Court first determined that the proper standard of review is one of correctness because the primary issue is one of statutory interpretation. The Court found that enantiomers are one of the enumerated list of variations of a previously approved medicinal ingredient that is expressly set out as not meeting the definition of "innovative drug". The Court held that, where there is some doubt as to whether a medicinal ingredient is a variation, the data submitted for approval is a relevant factor to consider in determining whether it is an innovative drug. The Court found that it was proper for the Minister to determine that the drug is not an innovative drug because it contains an enantiomer without considering the nature of the data submitted in the NDS.

Decision to Dismiss Opposition Reasonable
Mövenpick Holding AG v. Exxon Mobil Corporation

This is an appeal of the decision of the Trade-marks Opposition Board (TMOB), dismissing the opposition by Mövenpick to Exxon's application to register "Marché Express" (Mark).

The Court first noted the appropriate standard of review. In particular, the standard of review is reasonableness, unless new evidence is submitted and considered to be material to the decision, in which case the Court must review all the evidence and reach its own conclusion.

The Court first considered whether the proposed Mark is clearly descriptive and found that the finding of the TMOB that it is not clearly descriptive was reasonable. The Court further concluded that the new evidence submitted by both parties merely shored up the decision of the TMOB. The Court then considered confusion. The Court reviewed the new evidence, and concluded that there is no likelihood of confusion. Finally, the Court determined that the new evidence relating to date of first use merely shored up the evidence before the TMOB, and the decision of the TMOB that there was no doubt raised about the veracity of this date was reasonable. The Court noted that the rules of evidence must reflect those that govern proceedings before the TMOB.

Pre-judgment Interest in Provincial Act Waived by Election of Statutory Damages
Society of Composers, Authors and Music Publishers of Canada v. IIC Enterprises Ltd. c.o.b. as Cheetah's Nightclub

This is an appeal, by ex parte motion, of a Prothonotary's decision awarding default judgment. In particular, SOCAN appealed the Prothonotary's refusal to award pre-judgment interest from the date on which SOCAN's cause of action arose. Pre-judgment interest was awarded from the date of the Statement of Claim to the date of judgment.

The Court found that the issue of pre-judgment interest is governed by the Federal Courts Act because the case proceeded in the Federal Court. The Court found that the Prothonotary's decision that SOCAN waived its rights to provincial licence fees and therefore pre-judgment interest on that amount by electing statutory damages under the Copyright Act was correct.

Appeals Dismissed in Trade-mark Case as no Palpable or Overriding Error
Shapiro Cohen v. Empressa Cubana Del Tabaco Trading Also as Cubatabaco

The Court allowed the appeals from two decisions of the Registrar of Trade-marks (Registrar), expunging two trade-marks. The Court of Appeal considered two issues: whether the Court erred in finding that Cubatabaco had demonstrated control over the quality or character of the wares so as to benefit from the licensee's use in Canada; and whether the Court erred in finding that the trade-mark registration included cigars and cigarillos.

The Court of Appeal noted that the first issue was essentially a challenge to the Court's application of the legal test to the facts of the case. The Court of Appeal did not find any palpable or overriding error in the Court's consideration of the evidence. With respect to the second issue, new evidence before the Court supported the Court's finding. The appeals were dismissed.


Health Canada published a draft Guidance Document: The Use of Foreign Reviews by Health Canada – update to Appendix 3.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.